Atropine Sulfate Injection, Solution
Product Images NDC 64253-400

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 64253-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medefil, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Atropine)

Formula (Atropine)
Chemical structure of atropine sulfate, depicting the molecular arrangement including bicyclic tropane with attached ester and phenyl groups, with sulfate and water molecules indicated.*
FDA Label Image

Syringe Label (L4338 R001 Syringe Label)

Syringe Label (L4338 R001 Syringe Label)
Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL) in a 10 mL single-dose prefilled syringe for intravenous use. The label shows dosage strength, volume markings, and the manufacturer Medefil, Inc., Glendale Heights, IL. It includes the NDC number 64253-400-30 and indicates prescription use only.*
FDA Label Image

Package Insert Page 1 (L4353 R000 Pkg Insert Page 1)

Package Insert Page 1 (L4353 R000 Pkg Insert Page 1)
Prescribing information highlights for Atropine Sulfate Injection, 0.1 mg/mL intravenous solution. The text covers indications, dosage and administration details for adults and pediatric use, contraindications, warnings such as tachycardia and acute glaucoma, adverse reactions, drug interactions, and handling instructions. It includes a recommended dosage table and sections outlining full prescribing information content.*
FDA Label Image

Package Insert Page 2 (L4353 R000 Pkg Insert Page 2)

Package Insert Page 2 (L4353 R000 Pkg Insert Page 2)
This text panel provides detailed prescribing information for Atropine Sulfate Injection USP 0.1 mg/mL by Medefil, Inc. It includes sections on drug interactions, use in specific populations, overdose symptoms and treatment, a detailed description of the drug's chemical properties and formulation, clinical pharmacology, pharmacokinetics, nonclinical toxicology, and storage and handling instructions. The panel also features a table summarizing syringe concentration, fill volume, total atropine content, and NDC numbers for packaging.*
FDA Label Image

Master Carton Label (L4354 R000 Master Carton Label)

Master Carton Label (L4354 R000 Master Carton Label)
Label for Atropine Sulfate Injection, USP in a strength of 1 mg/10 mL (0.1 mg/mL) as a solution for intravenous use only. The label indicates this is a single-dose syringe and notes the storage conditions and pH range. It includes the NDC number 64253-400-91 and is labeled by Medefil, Inc., Glendale Heights, IL.*
FDA Label Image

Pouch Label (P3028 R000 Pouch Label)

Pouch Label (P3028 R000 Pouch Label)
Label for Atropine Sulfate Injection, USP 0.1 mg/mL in a 10 mL single-dose syringe for intravenous use. The label includes the NDC 64253-400-30 and states it is for prescription use only. Manufacturer is Medefil, Inc. The label also contains detailed drug composition and storage instructions, as well as barcoding and a note to discard unused portions.*
FDA Label Image

Dispenser Box 10 Count (10 mL)

Dispenser Box 10 Count (10 mL)
Packaging label for Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL) single-dose prefilled syringes by Medefil, Inc. The label features a purple background with black and white text sections. It states the product is for intravenous use, includes lot and expiration placeholders, and mentions discard of unused portions. The package contains 10 syringes of 10 mL each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.